Identification of cuproptosis-related lncRNAs signature for predicting the prognosis in patients with kidney renal clear cell carcinoma

被引:0
|
作者
He, Ya
Zhang, Hongxia
Li, Jingang
Zhou, Hui
Wang, Fei
Zhang, Guangliang
Wen, Yuetao [1 ]
机构
[1] Chongqing Univ, Jiangjin Hosp, Sch Med, Dept Neurosurg, 725 Jiangzhou Ave, Chongqing 402260, Peoples R China
来源
关键词
Cuproptosis; Cuproptosis-related lncRNAs; Kidney renal clear cell carcinoma; Tumor immune; LONG NONCODING RNA;
D O I
10.1016/j.jgeb.2023.100338
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Kidney renal clear cell carcinoma (KIRC), with low survival rate, is the most frequent subtype of renal cell carcinoma. Recently, more and more studies indicate that cuproptosis-related genes (CRGs) and long non-coding RNAs (lncRNAs) play a vital role in the occurrence and development of many types of cancers. However, the roles of cuproptosis-related lncRNAs (CRlncRNAs) in the KIRC was uncertain. Results: In our study, CRlncRNAs were obtained by coexpression between differentially expressed and prognostic CRGs and differentially expressed and prognostic lncRNAs, and an 8-CRlncRNAs (AC007743.1, AC022915.1, AP005136.4, APCDD1L-DT, HAGLR, LINC02027, MANCR and SMARCA5-AS1) risk model was established according to least absolute shrinkage and selection operator (LASSO) and multivariate Cox regression. This risk model could differentiate immune cell infiltration, immune function and gene mutation. Conclusions: This 8-CRlncRNAs risk model may be promising for the clinical prediction of prognoses, tumor immune, immunotherapy response and chemotherapeutic response in KIRC patients.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma
    Qiongyue Zhang
    Yan Huang
    Yu Xia
    Yumeng Liu
    Jianhe Gan
    Clinical and Experimental Medicine, 2023, 23 : 2051 - 2064
  • [32] Cuproptosis-related lncRNAs predict the prognosis and immune response in hepatocellular carcinoma
    Zhang, Qiongyue
    Huang, Yan
    Xia, Yu
    Liu, Yumeng
    Gan, Jianhe
    CLINICAL AND EXPERIMENTAL MEDICINE, 2023, 23 (06) : 2051 - 2064
  • [33] Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
    Chen, Yuqiao
    Tang, Lu
    Huang, Wentao
    Abisola, Fakolade Hannah
    Zhang, Youyu
    Zhang, Gewen
    Yao, Lei
    BIOLOGY DIRECT, 2023, 18 (01)
  • [34] Prognosis, Immune Microenvironment Infiltration and Immunotherapy Response in Clear Cell Renal Cell Carcinoma Based on Cuproptosis-related Immune Checkpoint Gene Signature
    Liu, Gang
    Li, Feifei
    Ge, Yuntian
    Shi, Yaxing
    Ren, Fang
    Zhu, Liancheng
    JOURNAL OF CANCER, 2023, 14 (17): : 3335 - 3350
  • [35] Cuproptosis-related lncRNAs predict prognosis and immune response of thyroid carcinoma
    Shi, Yinli
    Sheng, Pei
    Guo, Ming
    Chen, Kai
    Zhou, Hongguang
    Wu, Mianhua
    Li, Wenting
    Li, Bo
    FRONTIERS IN GENETICS, 2023, 14
  • [36] Up-regulation of Cuproptosis-related lncRNAS in Patients Receiving Immunotherapy for Metastatic Clear Cell Renal Cell Carcinoma Indicates Progressive Disease
    Katifelis, Hector
    Grammatikaki, Stamatiki
    Zakopoulou, Roubini
    Bamias, Aristotelis
    Karamouzis, Michalis, V
    Stravodimos, Konstantinos
    Gazouli, Maria
    IN VIVO, 2025, 39 (01): : 146 - 151
  • [37] Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma
    Zhou, Libin
    Fang, Hualong
    Guo, Fei
    Yin, Min
    Long, Huimin
    Weng, Guobin
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (08)
  • [38] Prognostic value and immunological characteristics of a novel cuproptosis-related long noncoding RNAs risk signature in kidney renal clear cell carcinoma
    Hong, Peng
    Huang, Weichao
    Du, Huifang
    Hu, Ding
    Cao, Qingfei
    Wang, Yinjie
    Zhang, Huashan
    Tong, Siqiao
    Li, Zizhi
    Tong, Ming
    FRONTIERS IN GENETICS, 2022, 13
  • [39] Identification and validation of a gap junction protein related signature for predicting the prognosis of renal clear cell carcinoma
    Huang, Yongsheng
    Guo, Wenyi
    Zeng, Yuan
    Wang, Xinrong
    Fan, Bohao
    Zhang, Ying
    Yan, Lei
    Gu, Gangli
    Liu, Zhao
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [40] Identification of a novel PANoptosis-related gene signature for predicting the prognosis in clear cell renal cell carcinoma
    Yue, Dezhi
    Ren, Congzhe
    Li, Hu
    Liu, Xiaoqiang
    MEDICINE, 2024, 103 (39)